Global Sterile Injectables Market, By Molecule Type (Large Molecules, Small Molecules), Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics), Therapeutic Application (Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal), End User (Hospitals, Drug Stores, Pharmacies, Online Pharmacies), and Geography - Insights, Opportunity Analysis, and Industry Forecast till
- Report code : CMI6201 |
- Industry :
Pharmaceutical
- Published On : Apr 2017 |
- Pages : 212 Pages |
- Format :
Sterile Injectables: Opportunities Galore for Generics Manufacturers
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide. According to Piramal, the development and manufacturing of sterile injectables is highly complex and capital intensive. The operative cost for injectable is high as almost all injectables in present pharma market are toxic and infectious in natural, consequently, requiring a higher level of quality and significant care needs to be taken in order to ensure safe manufacture, packaging, storage, and distribution. Furthermore, strict regulations by Food and Drugs Administration on manufacturing facilities and equipment dissuades pharma players and potential new entrants from venturing into this lucrative sterile injectables market. Many sterile manufacturing facilities have closed down in the U.S. and many parts worldwide due to the alliance of in-house manufacturing capacities, which have led to an acute shortage of sterile injectables, adversely affecting the sterile injectables market. Earlier, there were individual companies developing injectables have now merged and acquired similar product profile companies in order to make up for operational cost required to develop the injectable. This in turn has adversely affected the sterile injectable market, leading to dearth of drugs.
The global sterile injectable market was valued at US$ 299.7 billion in 2015 and is expected to witness a CAGR of 6.9% during the forecast period (2016 – 2024).
Figure 1. Global Sterile Injectables Market Share, By Product Type (%)
Source: Coherent Market Insights Analysis (2017)
Contract Manufacturing Firms to gain importance in Sterile Injectables Market
Sterile injectables manufacturing requires major capital investment for the equipment and the production process. Many pharmaceutical companies due to lack of funding and investors are approaching contract manufacturing firms in the U.S. and Europe. Lonza, one of the top contract manufacturer of biologics and ADC, in Europe, have ample opportunity to be the top contract manufacturing firm globally in terms of revenue. Germany-based pharma company, Fresenius Kabi, plans to invest around US$ 250 million over the following decade to expand the company’s Melrose Park site, where it manufactures generic, sterile injectable pharmaceuticals.
Sterile Injectables Market Scenario: Indian companies are increasingly focusing on developing complex generics:
Some of the prominent pharma companies based in India have strived hard to achieve success by attaining approval for various novel biologics processes. The manufacturing facilities for development of biologics are GMP certified. There are many complex injectable drugs such as lyophilized products, high potency active pharmaceutical ingredients, long-acting suspensions, and liposomes which necessitate multifaceted manufacturing capabilities. For injectables, new drug, including drug delivery systems such as self-injection devices such as auto and pen injectors that improve patient compliance and enable differentiation is a strategy employed by various market players. Dr. Reddy’s has marked up its multifaceted injectables business since past 5 years to US$ 280 million in 2015, which is almost equal to 25% of its market value from North America. In order to enhance its geographical presence and venture into the injectables product segment, the company acquired a Netherland-based injectables manufacturer, to expand its injectables product portfolio. Lupin Limited acquired Naomi BV in 2014. Naomi BV has an injectable drug in the development pipeline and approximately total number of 38 products in the development pipeline targeting branded and generic injectables market.
The last decade has witnessed a major paradigm shift in the healthcare industry, with increasing inclination towards biologics over conventional drugs. Therapeutic areas such as Oncology, drugs are been overtaken by biologics as they are highly absorbable in the body with quick therapeutic response. Furthermore, the pharmaceutical industry too has been swept by winds of change, with strong biologics pipeline under their product portfolio. Novel drug delivery systems that deliver specific targeted therapies are gaining importance. These aspects, among others, have in turn led to a spike in growth of the sterile injectables market. Globally, around 2,400 injectables s are under development pipeline, which are potent and non-potent. This is a major factor directly fueling growth of the sterile injectables s market. The generic market is the largest target market for sterile injectables s. Major generics players such as Teva Pharmaceuticals, Hospira, Hikma, and Fresenius Kabi are also involved in development of sterile injectables s.
Market Dynamics
Accessibility of broader treatment therapy choice and growing prevalence of chronic illnesses prominently cancer globally is likely to fuel market demand for sterile injectables s over the forecast period. The high demand for sterile injectables is also driven by a large number of drug manufacturers/producers concentrating on developing drugs to treat cancer. Fast-track regulatory approvals of sterile injectables and minimization of approval timelines for innovative drug development to cure cancer is indirectly helping accelerate the drug supply and is significantly fueling growth of the global sterile injectables market. High operative costs and abrupt termination of injectables drugs for cancer treatment is expected to hamper revenue growth of the market across the globe. Manufacturing of sterile products necessitate the high end equipment for manufacturing and also the equipment needs regulatory certification and sterilization before production process. Hence, these activities lead to high operating costs and high debt levels. Furthermore, the FDA has stringent regulations pertaining to sterilization of drug and equipment, which further adds to the cost burden of the manufacturer as it entails maintaining a high degree of care in the manufacturing, packaging, storage, and distribution of sterile injectables drugs.
Market Taxonomy
This report segments the sterile injectables market on the basis of molecule type, drug type, application, end user, and geography. On the basis of molecule type, the market is categorized into large molecules and small molecules. On the basis of drug type, the market is categorized into Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others. On the basis of application, the market is categorized into Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal and Others. On the basis of end user, the market is categorized into Hospitals, Drug Stores, Pharmacies and online pharmacies. For comprehensive understanding of market dynamics, the global sterile injectables market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
- This report provides in-depth analysis of the sterile injectables market which provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global sterile injectables market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Novartis AG, and Johnson & Johnson Services, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
- The global sterile injectables market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers for sterile injectables system, research and consulting firms, new entrants, and financial analysts
- Various strategy matrices used in analyzing the sterile injectables market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
- Global Sterile Injectables Market, By Molecule Type :
- Large Molecules
- Small Molecules
- Global Sterile Injectables Market, By Drug Type :
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Global Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Global Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Global Sterile Injectables Market, By Geography:
- North America
- U.S.
- U.S. Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- U.S. Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- U.S. Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- U.S. Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Canada
- Canada Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Canada Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Canada Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Canada Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Europe
- U.K.
- U.K. Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- U.K. Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- U.K. Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- U.K. Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Germany
- Germany Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Germany Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Germany Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Germany Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Italy
- Italy Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Italy Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Italy Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Italy Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- France
- France Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- France Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- France Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- France Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Spain
- Spain Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Spain Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Spain Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Spain Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Russia
- Russia Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Russia Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Russia Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Russia Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Rest of Europe
- Rest of Europe Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Rest of Europe Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Rest of Europe Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Rest of Europe Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Asia-Pacific
- China
- China Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- China Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- China Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- China Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- India
- India Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- India Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- India Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- India Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Japan
- Japan Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Japan Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Japan Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Japan Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- ASEAN
- ASEAN Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- ASEAN Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- ASEAN Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- ASEAN Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Australia
- Australia Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Australia Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Australia Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Australia Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- South Korea
- South Korea Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- South Korea Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- South Korea Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- South Korea Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Rest of Asia Pacific
- Rest of Asia Pacific Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Rest of Asia Pacific Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Rest of Asia Pacific Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Rest of Asia Pacific Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Latin America
- Brazil
- Brazil Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Brazil Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Brazil Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Brazil Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Mexico
- Mexico Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Mexico Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Mexico Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Mexico Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Rest of Latin America
- Rest of Latin America Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Rest of Latin America Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Rest of Latin America Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Rest of Latin America Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Middle East
- GCC
- GCC Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- GCC Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- GCC Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- GCC Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Israel
- Israel Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Israel Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Israel Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Israel Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Rest of Middle East
- Rest of Middle East Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Rest of Middle East Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Rest of Middle East Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Rest of Middle East Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Africa
- North Africa
- North Africa Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- North Africa Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- North Africa Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- North Africa Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Central Africa
- Central Africa Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- Central Africa Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- Central Africa Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- Central Africa Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- South Africa
- South Africa Sterile Injectables Market, By Molecule Type:
- Large Molecules
- Small Molecules
- South Africa Sterile Injectables Market, By Drug Type:
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
- South Africa Sterile Injectables Market, By Therapeutic Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Others
- South Africa Sterile Injectables Market, By End User:
- Hospitals
- Drug Stores
- Pharmacies
- Online Pharmacies
- Company Profiles
- Baxter International Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- AstraZeneca plc
- Merck & Co., Inc
- Novartis AG
- Johnson & Johnson Services, Inc
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Molecule Type
- Market Snippet By Drug Type
- Market Snippet By Therapeutic Application
- Market Snippet By End User
- Market Snippet By Geography
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Supply Side Drivers
- Demand Side Drivers
- Economic Drivers
- Restraints
- Market Opportunities
- Industry Trend
- Mergers and Acquisitions
- Investments
- Porter’s Five Force Analysis
- Pricing Analysis
- Global Sterile Injectable Market, By Molecule Type, 2014 - 2024 (US$ Billion)
- Introduction
- Market Share Analysis, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, 2014 - 2024
- Segment Trends
- Large Molecules
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Small Molecules
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Global Sterile Injectable Market, By Drug Type, 2014 - 2024 (US$ Billion)
- Introduction
- Market Share Analysis, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, 2014 - 2024
- Segment Trends
- Monoclonal Antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Cytokines
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Insulin
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Peptide Hormones
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Blood Factors
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Peptide Antibiotics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Global Sterile Injectable Market, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Introduction
- Market Share Analysis, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, 2014 - 2024
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Central Nervous Systems
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Global Sterile Injectable Market, By End User, 2014 - 2024 (US$ Billion)
- Introduction
- Market Share Analysis, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, 2014 - 2024
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Pharmacies
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
- Global Sterile Injectable Market, By Geography, 2014 - 2024 (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, For Regions, 2014 - 2024
- North America
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- U.S.
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Canada
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Europe
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- U.K.
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Germany
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Italy
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- France
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Spain
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Russia
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Rest of Europe
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Asia Pacific
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- China
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- India
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Japan
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- ASEAN
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Australia
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- South Korea
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Rest of Asia Pacific
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Latin America
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- Brazil
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Mexico
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Argentina
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Rest of Latin America
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Middle East
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- GCC Countries
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Israel
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Rest of Middle East
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Africa
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- Northern Africa
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Central Africa
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- South Africa
- Country Trends
- Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
- Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Baxter International Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- AstraZeneca plc,
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Merck & Co., Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Johnson & Johnson Services, Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 40 market data tables and 90 figures on "Sterile Injectable Market - Global forecast to 2024”.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
- Primary Research (Trade Surveys and Experts Interviews)
- Desk Research
- Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
- National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
- Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
- Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
- Trade association, National and international media and trade press.
- Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
- Scientific journals, and other technical magazines and whitepapers.
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Data Standardization:
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
- Micro-economic indicators
- Macro-economic indicators
- Environmental indicators
- Socio-political indicators
- Technology indicators
Data Processing
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
Data Validation
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
- It provides first-hand information on the market dynamics, outlook, and growth parameters.
- Industry experts validates the estimates which helps the company to cement the on-going research study.
- Primary research includes online surveys, face-to face interviews, and telephonic interviews.
The primary research is conducted with the ecosystem players including, but not limited to:
- Raw Material Suppliers
- Manufacturers
- System Integrators
- Distributors
- End-users
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.